cinnamophilin has been researched along with rhodamine 123 in 1 studies
| Studies (cinnamophilin) | Trials (cinnamophilin) | Recent Studies (post-2010) (cinnamophilin) | Studies (rhodamine 123) | Trials (rhodamine 123) | Recent Studies (post-2010) (rhodamine 123) |
|---|---|---|---|---|---|
| 13 | 0 | 5 | 1,760 | 10 | 424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, BH; Huang, SY; Hung, CC; Lee, TE; Teng, YN; Wu, IT; Wu, TS | 1 |
1 other study(ies) available for cinnamophilin and rhodamine 123
| Article | Year |
|---|---|
Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.
Topics: Adenosine Triphosphatases; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Cycle; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Guaiacol; Humans; Lignans; Molecular Docking Simulation; Rhodamine 123; Verapamil | 2021 |